Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diabetes

  Free Subscription


28.05.2018

1 Am J Kidney Dis
1 Am J Nephrol
1 Atherosclerosis
3 Biochem Biophys Res Commun
1 BMC Ophthalmol
10 Diabet Med
1 Diabetes
15 Diabetes Care
2 Diabetes Educ
4 Diabetes Obes Metab
2 Diabetologia
2 J Clin Endocrinol Metab
2 J Diabetes Complications
2 Kidney Int
2 Lancet
2 Lancet Diabetes Endocrinol
2 Ophthalmology
2 Pediatr Diabetes
6 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Kidney Dis

  1. KOYE DN, Magliano DJ, Reid CM, Jepson C, et al
    Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Am J Kidney Dis. 2018 May 18. pii: S0272-6386(18)30607.
    PubMed     Text format     Abstract available


    Am J Nephrol

  2. YAMAMOTO CM, Murakami T, Oakes ML, Mitsuhashi M, et al
    Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Am J Nephrol. 2018;47:283-291.
    PubMed     Text format     Abstract available


    Atherosclerosis

  3. COLOMBO M, Looker HC, Farran B, Agakov F, et al
    Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes.
    Atherosclerosis. 2018;274:182-190.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  4. LI X, Wu D, Tian Y
    Fibroblast growth factor 19 protects the heart from oxidative stress- induced diabetic cardiomyopathy via activation of AMPK/Nrf2/HO-1 pathway.
    Biochem Biophys Res Commun. 2018 May 18. pii: S0006-291X(18)31184.
    PubMed     Text format     Abstract available

  5. ZHANG J, Qiu H, Huang J, Ding S, et al
    Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice.
    Biochem Biophys Res Commun. 2018 May 17. pii: S0006-291X(18)31182.
    PubMed     Text format     Abstract available

  6. KHAN G, Aftab MF, Bano B, Khan KM, et al
    A new indanedione derivative alleviates symptoms of diabetes by modulating RAGE-NF-kappaB pathway in db/db mice.
    Biochem Biophys Res Commun. 2018 May 21. pii: S0006-291X(18)31092.
    PubMed     Text format     Abstract available


    BMC Ophthalmol

  7. HE Y, Ren XJ, Hu BJ, Lam WC, et al
    A meta-analysis of the effect of a dexamethasone intravitreal implant versus intravitreal anti-vascular endothelial growth factor treatment for diabetic macular edema.
    BMC Ophthalmol. 2018;18:121.
    PubMed     Text format     Abstract available


    Diabet Med

  8. TOFTE N, Lindhardt M, Adamova K, Beige J, et al
    Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes.
    Diabet Med. 2018 May 21. doi: 10.1111/dme.13669.
    PubMed     Text format     Abstract available

  9. DOJKI FK, Bakris GL
    Hyperkalaemia in diabetes: a silent risk predicting poor outcomes.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13683.
    PubMed     Text format     Abstract available

  10. LAFFEL L
    Lost in transition: finding a path forward for young adults with Type 1 diabetes.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13684.
    PubMed     Text format     Abstract available

  11. GRAHAM-ROWE E, Lorencatto F, Lawrenson JG, Burr JM, et al
    Barriers to and enablers of diabetic retinopathy screening attendance: a systematic review of published and grey literature.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13686.
    PubMed     Text format     Abstract available

  12. LI YG, Pastori D, Lip GYH
    Rivaroxaban for stroke prevention in people with atrial fibrillation and diabetes mellitus.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13685.
    PubMed     Text format     Abstract available

  13. THOMSEN RW, Nicolaisen SK, Adelborg K, Svensson E, et al
    Hyperkalaemia in people with diabetes: occurrence, risk factors and outcomes in a Danish population-based cohort study.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13687.
    PubMed     Text format     Abstract available

  14. LAZZARINI PA, Pacella RE, Armstrong DG, van Netten JJ, et al
    Diabetes-related lower-extremity complications are a leading cause of the global burden of disability.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13680.
    PubMed     Text format     Abstract available

  15. SELLMAN A, Katzman P, Andreasson S, Londahl M, et al
    Presence of chronic diabetic foot ulcers is associated with more frequent and more advanced retinopathy.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13682.
    PubMed     Text format     Abstract available

  16. MAMOULAKIS D, Vrouvaki F, Louvari V, Galanakis E, et al
    Incidence of childhood Type 1 diabetes mellitus in Crete.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13681.
    PubMed     Text format     Abstract available

  17. MONLUN M, Hugo M, Blanco L, Mohammedi K, et al
    Nerve action potential amplitudes, a robust marker of diabetic peripheral neuropathy.
    Diabet Med. 2018 May 23. doi: 10.1111/dme.13690.
    PubMed     Text format     Abstract available


    Diabetes


  18. In This Issue of Diabetes.
    Diabetes. 2018;67:1033-1034.
    PubMed     Text format    


    Diabetes Care

  19. MI MY, Mukamal KJ
    Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.
    Diabetes Care. 2018;41:e84-e85.
    PubMed     Text format    

  20. LAMPREA-MONTEALEGRE JA, de Boer IH
    Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes.
    Diabetes Care. 2018;41:1132-1133.
    PubMed     Text format    


  21. In This Issue of Diabetes Care.
    Diabetes Care. 2018;41:1119-1120.
    PubMed     Text format    

  22. RICKELS MR, DuBose SN, Toschi E, Beck RW, et al
    Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Diabetes Care. 2018 May 18. pii: dc18-0051. doi: 10.2337/dc18-0051.
    PubMed     Text format     Abstract available

  23. MATHIEU C
    Are We There Yet? Finding Ways to Work Together on T1D.
    Diabetes Care. 2018;41:667-669.
    PubMed     Text format    

  24. RIDDLE MC, Miller ME
    Scientific Exploration With Continuous Monitoring Systems: An Early Assessment of Arrhythmias During Hypoglycemia.
    Diabetes Care. 2018;41:664-666.
    PubMed     Text format    

  25. BUCKLEY LF, Dixon DL, Wohlford GF 4th, Wijesinghe DS, et al
    Response to Comment on Buckley et al. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738.
    Diabetes Care. 2018;41:e86-e87.
    PubMed     Text format    

  26. NEVES JS, Bigotte Vieira M, Leitao L, Viegas Dias C, et al
    Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408.
    Diabetes Care. 2018;41:e88-e89.
    PubMed     Text format    

  27. BRESS AP, Papademetriou V, Feinglos MN
    Response to Comment on Bress et al. Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial. Diabetes Care 2017;40:1401-1408.
    Diabetes Care. 2018;41:e90-e91.
    PubMed     Text format    

  28. HANSSEN NMJ, Westerink J, Scheijen JLJM, van der Graaf Y, et al
    Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease and Mortality in Individuals With Type 2 Diabetes.
    Diabetes Care. 2018 May 21. pii: dc18-0159. doi: 10.2337/dc18-0159.
    PubMed     Text format     Abstract available

  29. SUISSA S
    Response to Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e109-e110.
    PubMed     Text format    

  30. THURESSON M, Cavender MA, Fu AZ, Wilding JP, et al
    Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e106-e108.
    PubMed     Text format    

  31. NYSTROM T, Bodegard J, Nathanson D, Thuresson M, et al
    Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10.
    Diabetes Care. 2018;41:e104-e105.
    PubMed     Text format    

  32. KELLY CB, Hookham MB, Yu JY, Jenkins AJ, et al
    Response to Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.
    Diabetes Care. 2018;41:e102-e103.
    PubMed     Text format    

  33. FOUSSARD N, Cougnard-Gregoire A, Rajaobelina K, Delcourt C, et al
    Comment on Kelly et al. Subclinical First Trimester Renal Abnormalities Are Associated With Preeclampsia in Normoalbuminuric Women With Type 1 Diabetes. Diabetes Care 2018;41:120-127.
    Diabetes Care. 2018;41:e101.
    PubMed     Text format    


    Diabetes Educ

  34. HARTZLER ML, Shenk M, Williams J, Schoen J, et al
    Impact of Collaborative Shared Medical Appointments on Diabetes Outcomes in a Family Medicine Clinic.
    Diabetes Educ. 2018 May 1:145721718776597. doi: 10.1177/0145721718776597.
    PubMed     Text format     Abstract available

  35. PEYROT M, Egede L, Funnell M, Hsu W, et al
    US Ethnic Group Differences in Family Member Support for People With Diabetes in the 2nd Diabetes Attitudes, Wishes and Needs (DAWN2) Study.
    Diabetes Educ. 2018;44:249-259.
    PubMed     Text format     Abstract available


    Diabetes Obes Metab

  36. BELL DSH, Goncalves E
    Should we still be utilizing warfarin in the type 2 diabetic patient?
    Diabetes Obes Metab. 2018 May 22. doi: 10.1111/dom.13371.
    PubMed     Text format     Abstract available

  37. KAWASAKI R, Konta T, Nishida K
    Lipid-lowering medication use is associated with decreased risk of diabetic retinopathy and its treatments in patients with type 2 diabetes: a real-world observational analysis of a health claims database.
    Diabetes Obes Metab. 2018 May 22. doi: 10.1111/dom.13372.
    PubMed     Text format     Abstract available

  38. CAO B, Rosenblat JD, Brietzke E, Park C, et al
    Comparative Efficacy and Acceptability of Anti-Diabetic Agents for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Network Meta-analysis.
    Diabetes Obes Metab. 2018 May 23. doi: 10.1111/dom.13373.
    PubMed     Text format     Abstract available

  39. LESLIE RD, Pozzilli P, Peters AL, Buzzetti R, et al
    Response to the comment on Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2,-4 and -5 Trials.
    Diabetes Obes Metab. 2018 May 20. doi: 10.1111/dom.13366.
    PubMed     Text format     Abstract available


    Diabetologia

  40. JENKINS DJA, Kendall CWC, Lamarche B, Banach MS, et al
    Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trial.
    Diabetologia. 2018 May 23. pii: 10.1007/s00125-018-4628.
    PubMed     Text format     Abstract available

  41. VERMA S, Mazer CD, Fitchett D, Inzucchi SE, et al
    Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME(R) randomised trial.
    Diabetologia. 2018 May 19. pii: 10.1007/s00125-018-4644.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  42. MARATHE CS, Rayner CK, Wu T, Jones KL, et al
    Gastric Emptying and the Personalized Management of Type 1 Diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996517. doi: 10.1210/jc.2018-00849.
    PubMed     Text format    

  43. OTTOSSON F, Smith E, Melander O, Fernandez C, et al
    Altered asparagine and glutamate homeostasis precede coronary artery disease and type-2 diabetes.
    J Clin Endocrinol Metab. 2018 May 16. pii: 4996516. doi: 10.1210/jc.2018-00546.
    PubMed     Text format     Abstract available


    J Diabetes Complications

  44. REN J, Ma F, Zhou Y, Xu A, et al
    Hearing impairment in type 2 diabetics and patients with early diabetic nephropathy.
    J Diabetes Complications. 2018 Apr 5. pii: S1056-8727(17)31620.
    PubMed     Text format     Abstract available

  45. LUU QF, Villareal CJ, Fritschi C, Monson RS, et al
    Concerns and hopes of patients with type 1 diabetes prior to islet cell transplantation: A content analysis.
    J Diabetes Complications. 2018 Apr 17. pii: S1056-8727(17)31135.
    PubMed     Text format     Abstract available


    Kidney Int

  46. BOMSZTYK K, Denisenko O, Wang Y
    DNA methylation yields epigenetic clues into the diabetic nephropathy of Pima Indians.
    Kidney Int. 2018;93:1272-1275.
    PubMed     Text format     Abstract available

  47. GROVE KJ, Lareau NM, Voziyan PA, Zeng F, et al
    Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney.
    Kidney Int. 2018 May 17. pii: S0085-2538(18)30202.
    PubMed     Text format     Abstract available


    Lancet

  48. GREGG EW, Cheng YJ, Srinivasan M, Lin J, et al
    Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data.
    Lancet. 2018 May 18. pii: S0140-6736(18)30314.
    PubMed     Text format     Abstract available

  49. BENNETT PH
    Diabetes mortality in the USA: winning the battle but not the war?
    Lancet. 2018 May 18. pii: S0140-6736(18)30843.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  50. FORBES S, Senior PA, Shapiro AMJ
    Islet transplantation in type 1 diabetes: moving forward.
    Lancet Diabetes Endocrinol. 2018 May 15. pii: S2213-8587(18)30107.
    PubMed     Text format    

  51. LABLANCHE S, Vantyghem MC, Kessler L, Wojtusciszyn A, et al
    Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lancet Diabetes Endocrinol. 2018 May 15. pii: S2213-8587(18)30078.
    PubMed     Text format     Abstract available


    Ophthalmology

  52. KLEIN R, Lee KE, Danforth L, Tsai MY, et al
    The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
    Ophthalmology. 2018 May 17. pii: S0161-6420(18)30530.
    PubMed     Text format     Abstract available

  53. WONG TY, Sun J, Kawasaki R, Ruamviboonsuk P, et al
    Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings.
    Ophthalmology. 2018 May 15. pii: S0161-6420(17)33523.
    PubMed     Text format     Abstract available


    Pediatr Diabetes

  54. HANNON TS, Saha C, Carroll AE, Palmer KNB, et al
    The ENCOURAGE Healthy Families Study: A Comparative Effectiveness Trial to Reduce Risk for Type 2 Diabetes in Mothers and Children.
    Pediatr Diabetes. 2018 May 20. doi: 10.1111/pedi.12692.
    PubMed     Text format     Abstract available

  55. BIRKEBAEK NH, Kahlert J, Bjarnason R, Drivvoll AK, et al
    Body mass index standard deviation score and obesity in children with type 1 diabetes in the Nordic countries. HbA1c and other predictors of increasing BMISDS.
    Pediatr Diabetes. 2018 May 21. doi: 10.1111/pedi.12693.
    PubMed     Text format     Abstract available


    PLoS One

  56. ROMERO-IBARGUENGOITIA ME, Vadillo-Ortega F, Caballero AE, Ibarra-Gonzalez I, et al
    Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach.
    PLoS One. 2018;13:e0193138.
    PubMed     Text format     Abstract available

  57. ZHANG Y, Warnock GL, Ao Z, Park YJ, et al
    Amyloid formation reduces protein kinase B phosphorylation in primary islet beta-cells which is improved by blocking IL-1beta signaling.
    PLoS One. 2018;13:e0193184.
    PubMed     Text format     Abstract available

  58. THOMPSON K, Chen J, Luo Q, Xiao Y, et al
    Advanced glycation end (AGE) product modification of laminin downregulates Kir4.1 in retinal Muller cells.
    PLoS One. 2018;13:e0193280.
    PubMed     Text format     Abstract available

  59. LAM D, Momeni Z, Theaker M, Jagadeeshan S, et al
    RAGE-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose.
    PLoS One. 2018;13:e0193312.
    PubMed     Text format     Abstract available

  60. MEN P, Li XT, Tang HL, Zhai SD, et al
    Efficacy and safety of saxagliptin in patients with type 2 diabetes: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0197321.
    PubMed     Text format     Abstract available

  61. TAIT CA, L'Abbe MR, Smith PM, Rosella LC, et al
    The association between food insecurity and incident type 2 diabetes in Canada: A population-based cohort study.
    PLoS One. 2018;13:e0195962.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: